Fixed Mobile Convergence Industry News

TMCNet: Increased Capital Funding for Unisense FertiliTech A/S Will Help Meet Demand for New Assisted Reproduction Device

[December 16, 2009]

Increased Capital Funding for Unisense FertiliTech A/S Will Help Meet Demand for New Assisted Reproduction Device

Aarhus, Denmark, Dec 16, 2009 (PRWeb.com via COMTEX) -- Unisense FertiliTech A/S has received a further 1.6 million Euro in capital funding to scale up production and support of the EmbryoScope(TM) Embryo Monitoring System in order to meet the rapidly growing demand for this promising new technology. The capital was invested by LD Pensions and Unisense A/S that continue to own each about 50% of the company.

During IVF treatment, multiple oocytes are removed from the patient and fertilized in-vitro. The resulting fertilized eggs are allowed to develop for a period of 2 to 5 days, before the embryologist must select the best potential embryo or embryos to transfer back to the patient. Ideally, a single embryo resulting in a single pregnancy is optimal as multiple pregnancies present risks to both maternal and fetal health.

A major challenge for the embryologist is determining which embryos have the best potential to create a single healthy baby. The EmbryoScope(R) Embryo Monitoring System allows uninterrupted time-lapse observation of embryo development in a stable controlled incubation environment. Embryo quality parameters can be assessed and reviewed without the potentially damaging effects of removing the embryo from a stable controlled environment.

CEO Jens Gundersen says they are encouraged with the overwhelming response to the initial sales launch of the instrument, and that with the additional capital, FertiliTech will be able to scale up production to meet the demands of the rapidly expanding interest for the EmbryoScope(R) Embryo monitoring system.

Unisense FertiliTech A/S is a Danish company which was founded in 2003, as a daughter company of Unisense A/S. The company develops and manufactures instruments and analysis solutions to facilitate in-vitro Fertilization. The company is highly research oriented and is currently involved in various international research projects involving improved embryo selection and analysis, embryo respiration and stem cell research.

Contact Person: Francesca Bahr Sales and Marketing Manager Unisense FertiliTech A/S Phone Number +45 89449525 Mobile Phone: +45 40255538 Jens K. Gundersen CEO +45 21601675 Email Address fab (at) fertilitech (dot) com Website URL http://www.fertilitech.com ### Read the full story at http://www.prweb.com/releases/2009/12/prweb3339374.htm.

PRWeb.com

[ Back To Fixed Mobile Convergence Homepage's Homepage ]


Related Fixed Mobile Convergence Articles
[ View all Fixed Mobile Convergence Articles ]


Socialize with Us

FREE Fixed Mobile Convergence eNewsletter

Click here to receive your targeted Fixed Mobile Convergence Community eNewsletter.
Subscribe Now

Latest Industry News

View all Fixed Mobile Convergence News

Our Partners

  • Thrupoint is committed to providing unsurpassed technology and consulting services to leaders in the networked economy. We deliver value to our partners by giving them access to our award winning Ubiquity communications platform and NGIC Applications. Our ecosystem is at the ready to help propel the sales of our partners with best-in-class technology solutions, combining strategic resources to deliver high-value competitive advantage to our clients.
  • Learn More ››

Our Fixed Mobile Convergence Products

  • Thrupoint is committed to providing unsurpassed technology and consulting services to leaders in the networked economy. We deliver value to our partners by giving them access to our award winning Ubiquity communications platform and NGIC Applications. Our ecosystem is at the ready to help propel the sales of our partners with best-in-class technology solutions, combining strategic resources to deliver high-value competitive advantage to our clients.
  • Learn More ››